Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,885Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8BAYER HEALTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 8975254

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-25

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 9657003

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 10010530

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 11046713

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 10383853

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 11168058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-27

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DAROLUTAMIDE

US Patent Number : 10711013

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

blank